163 related articles for article (PubMed ID: 31237072)
1. Phosphorylated STAT3 expression predicts better prognosis in smoldering type of adult T-cell leukemia/lymphoma.
Morichika K; Karube K; Kayo H; Uchino S; Nishi Y; Nakachi S; Okamoto S; Morishima S; Ohshiro K; Nakazato I; Fukushima T; Masuzaki H
Cancer Sci; 2019 Sep; 110(9):2982-2991. PubMed ID: 31237072
[TBL] [Abstract][Full Text] [Related]
2. The importance of the clinical classification of adult T-cell leukemia/lymphoma (ATLL) in the prognosis.
Oliveira PD; Ribeiro GS; Anjos RO; Dias MA; Farre L; Araújo I; Bittencourt AL
PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010807. PubMed ID: 36260617
[TBL] [Abstract][Full Text] [Related]
3. Prognostic analysis of smoldering ATLL with skin eruptions based on genomic aberrations.
Mochida K; Nakahata S; Suzuki Y; Inoue K; Moriguchi S; Yamashita A; Amano M; Morishita K
J Dermatol Sci; 2023 Feb; 109(2):80-88. PubMed ID: 36842846
[TBL] [Abstract][Full Text] [Related]
4. C-MYC and Its Main Ubiquitin Ligase, FBXW7, Influence Cell Proliferation and Prognosis in Adult T-cell Leukemia/Lymphoma.
Mihashi Y; Mizoguchi M; Takamatsu Y; Ishitsuka K; Iwasaki H; Koga M; Urabe K; Momosaki S; Sakata T; Kiyomi F; Takeshita M
Am J Surg Pathol; 2017 Aug; 41(8):1139-1149. PubMed ID: 28498285
[TBL] [Abstract][Full Text] [Related]
5. CCR4 frameshift mutation identifies a distinct group of adult T cell leukaemia/lymphoma with poor prognosis.
Yoshida N; Miyoshi H; Kato T; Sakata-Yanagimoto M; Niino D; Taniguchi H; Moriuchi Y; Miyahara M; Kurita D; Sasaki Y; Shimono J; Kawamoto K; Utsunomiya A; Imaizumi Y; Seto M; Ohshima K
J Pathol; 2016 Apr; 238(5):621-6. PubMed ID: 26847489
[TBL] [Abstract][Full Text] [Related]
6. New entity, definition and diagnostic criteria of cutaneous adult T-cell leukemia/lymphoma: human T-lymphotropic virus type 1 proviral DNA load can distinguish between cutaneous and smoldering types.
Amano M; Kurokawa M; Ogata K; Itoh H; Kataoka H; Setoyama M
J Dermatol; 2008 May; 35(5):270-5. PubMed ID: 18477226
[TBL] [Abstract][Full Text] [Related]
7. Molecular Pathology of Adult T-Cell Leukemia/Lymphoma.
Ohshima K
Oncology; 2015; 89 Suppl 1():7-15. PubMed ID: 26550829
[TBL] [Abstract][Full Text] [Related]
8. Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma.
Kataoka K; Iwanaga M; Yasunaga JI; Nagata Y; Kitanaka A; Kameda T; Yoshimitsu M; Shiraishi Y; Sato-Otsubo A; Sanada M; Chiba K; Tanaka H; Ochi Y; Aoki K; Suzuki H; Shiozawa Y; Yoshizato T; Sato Y; Yoshida K; Nosaka K; Hishizawa M; Itonaga H; Imaizumi Y; Munakata W; Shide K; Kubuki Y; Hidaka T; Nakamaki T; Ishiyama K; Miyawaki S; Ishii R; Nureki O; Tobinai K; Miyazaki Y; Takaori-Kondo A; Shibata T; Miyano S; Ishitsuka K; Utsunomiya A; Shimoda K; Matsuoka M; Watanabe T; Ogawa S
Blood; 2018 Jan; 131(2):215-225. PubMed ID: 29084771
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous presentation of adult T-cell leukemia/lymphoma (ATLL). Single-center study on 37 patients in metropolitan France between 1996 and 2016.
Hurabielle C; Battistella M; Ram-Wolff C; Fite C; Meignin V; Rivet J; Vignon-Pennamen MD; de Risi-Pugliese T; Raffoux E; Arnulf B; Oksenhendler E; Sicre de Fontbrune F; Peffault de Latour R; Socié G; Bouaziz JD; Lebbé C; Bensussan A; Bagot M
Ann Dermatol Venereol; 2018; 145(6-7):405-412. PubMed ID: 29661476
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive immunohistochemical analysis of immune checkpoint molecules in adult T cell leukemia/lymphoma.
Takeuchi M; Miyoshi H; Nakashima K; Kawamoto K; Yamada K; Yanagida E; Muta H; Moritsubo M; Umeno T; Suzuki T; Seto M; Ohshima K
Ann Hematol; 2020 May; 99(5):1093-1098. PubMed ID: 32157421
[TBL] [Abstract][Full Text] [Related]
11. Prospects of early therapeutic interventions for indolent adult T-cell leukemia/lymphoma based on the chronic lymphocytic leukemia progression model.
Ohmoto A; Fuji S
Blood Rev; 2023 Jul; 60():101057. PubMed ID: 36828681
[TBL] [Abstract][Full Text] [Related]
12. Role of tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL).
Hatta Y; Koeffler HP
Leukemia; 2002 Jun; 16(6):1069-85. PubMed ID: 12040438
[TBL] [Abstract][Full Text] [Related]
13. pSTAT3 and MYC in Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Teoh SH; Khoo JJ; Abdul Salam DSD; Peh SC; Cheah SC
Malays J Pathol; 2019 Dec; 41(3):273-281. PubMed ID: 31901912
[TBL] [Abstract][Full Text] [Related]
14. Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.
Haura EB; Zheng Z; Song L; Cantor A; Bepler G
Clin Cancer Res; 2005 Dec; 11(23):8288-94. PubMed ID: 16322287
[TBL] [Abstract][Full Text] [Related]
15. TACC3 expression as a prognostic factor in aggressive types of adult T-cell leukemia/lymphoma patients.
Moritsubo M; Miyoshi H; Matsuda K; Yoshida N; Nakashima K; Yanagida E; Yamada K; Takeuchi M; Suzuki T; Muta H; Umeno T; Furuta T; Seto M; Ohshima K
Int J Lab Hematol; 2020 Dec; 42(6):842-848. PubMed ID: 32744749
[TBL] [Abstract][Full Text] [Related]
16. Impact of STAT3 phosphorylation on the clinical effectiveness of anti-EGFR-based therapy in patients with metastatic colorectal cancer.
Dobi E; Monnien F; Kim S; Ivanaj A; N'Guyen T; Demarchi M; Adotevi O; Thierry-Vuillemin A; Jary M; Kantelip B; Pivot X; Godet Y; Degano SV; Borg C
Clin Colorectal Cancer; 2013 Mar; 12(1):28-36. PubMed ID: 23083634
[TBL] [Abstract][Full Text] [Related]
17. Karyotypic complexity, TP53 pathogenic variants, and increased number of variants on Next-Generation Sequencing are associated with disease progression in a North American Adult T-Cell Leukemia/Lymphoma cohort.
Zhang X; Shi Y; Ramesh KH; Naeem R; Wang Y
Int J Lab Hematol; 2021 Aug; 43(4):651-657. PubMed ID: 33988304
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of ASY/Nogo transcription associated with progression of adult T-cell leukemia/lymphoma.
Shimakage M; Inoue N; Ohshima K; Kawahara K; Oka T; Yasui K; Matsumoto K; Inoue H; Watari A; Higashiyama S; Yutsudo M
Int J Cancer; 2006 Oct; 119(7):1648-53. PubMed ID: 16646068
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of serum Th1-, Th2- and regulatory T cells-associated cytokines in adult T-cell leukemia/lymphoma: high interleukin-5 and -10 levels are significant unfavorable prognostic factors.
Inagaki A; Ishida T; Ishii T; Komatsu H; Iida S; Ding J; Yonekura K; Takeuchi S; Takatsuka Y; Utsunomiya A; Ueda R
Int J Cancer; 2006 Jun; 118(12):3054-61. PubMed ID: 16425276
[TBL] [Abstract][Full Text] [Related]
20. STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells.
Hazan-Halevy I; Harris D; Liu Z; Liu J; Li P; Chen X; Shanker S; Ferrajoli A; Keating MJ; Estrov Z
Blood; 2010 Apr; 115(14):2852-63. PubMed ID: 20154216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
